These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 8523091)

  • 1. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?
    O'Neill BP; Dinapoli RP; Kurtin PJ; Habermann TM
    J Neurooncol; 1995; 25(1):67-71. PubMed ID: 8523091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series.
    Chamberlain MC
    J Neurooncol; 2013 May; 113(1):27-32. PubMed ID: 23456654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.
    Ferreri AJ; Reni M; Zoldan MC; Terreni MR; Villa E
    Cancer; 1996 Mar; 77(5):827-33. PubMed ID: 8608471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary CNS lymphoma: findings outside the brain.
    Herrlinger U
    J Neurooncol; 1999 Jul; 43(3):227-30. PubMed ID: 10563427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of body FDG PET in staging primary central nervous system lymphoma.
    Mohile NA; Deangelis LM; Abrey LE
    Neuro Oncol; 2008 Apr; 10(2):223-8. PubMed ID: 18287338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphoma: presentation, diagnosis and staging.
    Eichler AF; Batchelor TT
    Neurosurg Focus; 2006 Nov; 21(5):E15. PubMed ID: 17134117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
    Akkas BE; Vural GU
    Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.
    Margold M; Seidel S; Kowalski T; Ladigan-Badura S; Baraniskin A; Schroers R; Frey AV; Schmidt-Wolf IGH; Herrlinger U; Korfel A; Schlegel U
    Neuro Oncol; 2021 Dec; 23(12):2076-2084. PubMed ID: 33984138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary central nervous system lymphoma.
    Shah GD; DeAngelis LM
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):611-27, v. PubMed ID: 16083826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma.
    Tesoro-Tess JD; Balzarini L; Ceglia E; Petrillo R; Santoro A; Musumeci R
    Eur J Radiol; 1991; 12(2):81-90. PubMed ID: 2037005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
    Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
    Norrington M; Rathi N; Jenkinson MD; Mills SJ
    J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
    Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
    Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular involvement in primary central nervous system lymphoma: an increasing clinical problem?
    Roos DE; O'Brien PC; Crompton JL
    Australas Radiol; 1993 Nov; 37(4):372-4. PubMed ID: 8257339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Central Nervous System Lymphoma.
    Sinicrope K; Batchelor T
    Neurol Clin; 2018 Aug; 36(3):517-532. PubMed ID: 30072069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.